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Background: Urinary tract infections (UTI) causedby extended-
spectrum -lactamase (ESBL)-producing organisms are a major
burden in clinical practice. Hospitalization in the past 3 months,
antibiotic treatment in the past 3 months, age over 60 years, dia-
betes mellitus, Klebsiella pneumoniae infection, previous use of
second or third-generation cephalosporins, quinolones or peni-
cillins are known associations and risk factors for ESBL-UTI.
Methods & Materials: A descriptive study was conducted over
a period of 6 months from January - July 2015 recruiting patients
with UTI caused by ESBL producing organisms, who were admitted
to the Professorial Medical unit, Colombo North Teaching Hospital,
Ragama Sri Lanka in order to identify risk factors and associations.
Data were obtained using a pre-tested interviewer administered
questionnaire and from relevant medical records after obtaining
informed written consent.
Results: 52 patients were recruited; males 30 (57.7%), mean
(SD) age 64.1(.12.6)years. Of them, 46 (88.5%) had diabetes mel-
litus, 32 (61.5%) had hypertension and 10 (19.2%) had chronic
liver disease as comorbidities.20 (38.5%) had ultrasonographic
evidence of acute pyelonephritis. At presentation16 (30.8%)had
biochemical and/or ultrasonographic evidence of chronic or
acute on chronic kidney disease. History of constipation was
observed in 18 (34.6%), hospitalization during the past 3 months
was seen in 24(46.2%)and history of urinary catheterization in
16(30.8%). Features of obstructive uropathy such as hydronephro-
sis, hydroureter and prostatomegaly were seen in 4 (7.7%)
patients each. Antibiotic treatment within the past 3 months
was observed in 32(61.5%);penicillins in 18(34.6%), 3rd generation
cephalosporins in 16(30.8%),quinolones in 14(26.9%) and 2nd gen-
eration cehalosporins in 12 (23.1%). 18 (34.6%) had received more
than one antibiotic within the past 3 months. 8(15.4%)patients
studied were on prophylactic antibiotics for recurrant UTIs. None
of them had recent Klebsiella pneumonia.
Conclusion: Similar to other studies,diabetes mellitus, recent
antibiotic treatment, hospitalization and catheterization were
observed in our patients with ESBL-UTI. The fact thatonly 53.8%
patients had received antibiotics at community level and 38.5%
patients had never received antibiotics prior to developing ESBL-
UTIsuggest high prevalence of ESBL producing organisms at
community level.
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Pathogenetic signiﬁcance of macrophage
inﬂammatory protein-IA in patients with
erysipelas of the lower extremities
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Background: The aim of study was to clarify the biochemical
mechanisms of severe hemorrhagic forms of erysipelas and ﬁnd
the possible early predictors of its development.
Methods & Materials: 90 patients with erysipelas of the lower
extremities (ELE) were examined. 44 patients had erythema-
tous (1th group), 24 - bullous (2th group) and 32 - hemorrhagic
(3th group) forms of ELE. The level of macrophage inﬂammatory
protein-1A (MIP-1a) was investigated in the dynamics of ELE. Also
we studied the phagocytic activity of neutrophils and monocytes.
Results: In the acute phase of disease the level of MIP-1a in 1th
and 2th groups was lower than in healthy individuals: 9.10pg/ml
(95%CL 7.84-10.36pg/ml), 10.8pg/ml (95%CI 9.43±12.17pg/ml)
and 13.6pg/ml (95%CI 11.88±15.32pg/ml) accordingly, p-value 1-
n=0.03, p-value 2-n=0.04. In 3th group it was signiﬁcantly higher
in comparison with all other groups 290.7pg/ml (95%CI 284.49-
296.91pg/ml).
Phagocytic activity was considerably higher in patients of 3th
group than inpatientsof1thgroup:92,5% (95%CI91.88-93.12%)and
83,5% (95%CI 82.49- 84.51%) for neutrophils (p-value 1-3=0.001)
and 88,5% (95%CI 87.94-89.06%) and 80,0% (95%CI 77.77-82.23%)
for monocytes (p-value 1-3=0.002).
In the convalescent period the level of MIP-1a increased to
11.7 pg/ml (95%CI 8.14-15.26pg/ml) at erythematous form and
13.5% (95%CI 10.26-16.74 pg/ml) at bullous form without differ-
ence between them and normal level. In 3th group it was down to
the level of a norm 13.7 pg/ml (95%CI 10.46-16.94 pg/ml). Within
12 months of follow-up period we observed only 1 relapse in 3th
group, 3 - in 2th group and 6 in 1th group.
Conclusion: Identiﬁed changes in the level MIP-1a reﬂect its
role in the implementation of the phagocytic activity. Mostly it
refers to the monocytes, as evidenced by an increase in its level in
patients with hemorrhagic form of erysipelas, where their activity
was maximal.
Signiﬁcant reduction of relapses in patients with hemorrhagic
erysipelas probably connected with increased PA, which can stim-
ulate nonspeciﬁc resistance via activation of phagocytosis.
http://dx.doi.org/10.1016/j.ijid.2016.02.355
